Clinical Trial Update: TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating a Toll-like receptor 9 adjuvanted vaccine for chronic hepatitis B. The study is currently recruiting and sponsored by the Un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• TLR-9 adjuvanted vaccine

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Hepatitis B, Chronic Hepatitis B | Phase 1 | Status: RECRUITING